OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis $2.35 0.00 (0.00%) As of 10/2/2024 Add Compare Share Share Stock Analysis Stock Analysis About Augmedix Stock (OTCMKTS:AUGX) Get Augmedix alerts:Sign Up Key Stats Today's Range$2.35▼$2.3550-Day Range$2.35▼$2.3552-Week Range$0.73▼$6.25VolumeN/AAverage Volume635,746 shsMarket Capitalization$115.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Augmedix, Inc. was a healthcare technology company that developed solutions to reduce the administrative burden associated with clinical documentation. Its platform used artificial intelligence, natural language processing and, in some offerings, trained medical documentation specialists to convert patient-clinician conversations into structured medical notes. The company’s products were designed to support physicians and other healthcare professionals during and after patient visits. Its offerings included ambient documentation tools that captured and summarized clinical conversations, as well as services that combined automation with human review. These solutions were intended to integrate with electronic health record systems and help healthcare organizations improve workflow efficiency and give clinicians more time to focus on patient care. Founded in 2012, Augmedix primarily served healthcare providers and enterprise customers in the United States, with its technology used across multiple medical specialties and care settings. Augmedix became a publicly traded company in 2021. In 2024, the company was acquired by Commure, a healthcare technology platform, and Augmedix subsequently ceased operating as an independent public company.AI Generated. May Contain Errors. Read More Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUGX Stock News HeadlinesAugmedix Delivers 27% Revenue Growth for Second Quarter of 2024June 10, 2026 | stockhouse.comLake Street Downgrades Augmedix (AUGX)July 23, 2024 | msn.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 16 at 1:00 AM | Weiss Ratings (Ad)SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Augmedix, Inc. BuyoutJuly 22, 2024 | stockhouse.comAugmedix Agrees to $139 Million Acquisition by CommureJuly 19, 2024 | marketwatch.comAUGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Augmedix, Inc. Is Fair to ShareholdersJuly 19, 2024 | tmcnet.comAI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M DealJuly 19, 2024 | msn.comAugmedix to be acquired by Commure in transaction valuing the former at ~$139MJuly 19, 2024 | msn.comSee More Headlines AUGX Stock Analysis - Frequently Asked Questions How have AUGX shares performed this year? Augmedix's stock was trading at $2.35 on January 1st, 2026. Since then, AUGX shares have increased by 0.0% and is now trading at $2.35. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) announced its quarterly earnings data on Monday, March, 27th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. The company earned $8.75 million during the quarter, compared to analyst estimates of $8.52 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%. Company Calendar Last Earnings3/27/2023Today10/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolOTCMKTS:AUGX CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees710Year Founded2012Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$24.45 million Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$51.58 million Price / Sales2.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book23.50Miscellaneous Outstanding Shares48,968,000Free Float36,316,000Market Cap$115.07 million OptionableNot Optionable Beta-0.22 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:AUGX) was last updated on 10/2/2024 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AUGX Stock Alerts